Memphasys Ltd

IG7

Company Profile

  • Business description

    Memphasys Ltd is an Australian reproductive biotechnology company developing and commercializing novel reproduction and fertility solutions for humans and animals. The products in its development pipeline include a range of devices, media, and in vitro diagnostic solutions. The company is currently focused on the commercialisation of its patented Felix System, a novel bio-separation technology for assisted reproduction, designed to revolutionise sperm separation in assisted reproductive technology (ART) by providing a rapid, gentle, and automated process. The group has only one operating segment, being Reproductive Technologies, the assets and liabilities of which are located in Australia.

  • Contact

    34-36 Richmond Road
    Level 1
    Homebush West
    SydneyNSW2140
    AUS

    T: +61 284157300

    https://www.memphasys.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 June 2027

    Employees

    28

Stocks News & Analysis

stocks

Big 4 earnings: Morningstar analysts form view on impact of slowing housing market

Big 4 bank maintains Fair Value, Short-term earnings not material enough to shift valuation for key player
stocks

ASX healthcare share remains cheap despite mixed earnings result

Shares in Aussie listed healthcare name undervalued post earnings.
stocks

Wide moat ASX share beats earnings guidance

Wide moat share continues to grow despite a challenging residential construction market.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,404.700.80-0.01%
CAC 408,674.9440.00-0.46%
DAX 4026,331.0760.35-0.23%
Dow JONES (US)53,839.9348.080.09%
FTSE 10010,833.1511.04-0.10%
HKSE25,440.17212.65-0.83%
NASDAQ26,579.09133.640.51%
Nikkei 22567,524.06553.840.83%
NZX 50 Index13,737.66123.00-0.89%
S&P 5007,747.8719.670.25%
S&P/ASX 2009,209.402.20-0.02%
SSE Composite Index3,946.6812.580.32%

Market Movers